a parallel, randomised, open-label clinical trial evaluating the safety and efficacy of methotrexate with apremilast in patients with moderate to severe palmoplantar psoriasis. Int. J. Pharm. Sci. Lett. [Internet]. 2021 Apr. 13 [cited 2026 Oct. 14];11(2):1-11. Available from: https://ijpsl.org/index.php/ijpls/article/view/21